COMPARE · Data as of August 27, 2026

STAG vs TRNO

Verdict: Side-by-side breakdown using the Bull Rankings model. STAG scored 70.0, TRNO scored 74.0 — TRNO leads.
Compare another set
STAG
STAG Industrial, Inc.
REIT - Industrial · Financial strength
67.9Fin
$37.07 · $7.3B
fundamentals as of
Strength gap
4.7
TRNO leads
TRNO
Terreno Realty Corporation
REIT - Industrial · Financial strength
72.6Fin
$67.11 · $7.3B
fundamentals as of
  • Fastest growthTRNO+24.5%
  • Strongest balance sheetTRNO0.21
THE BULL RANKINGS SCORECARD67.9/ 100 · FIN STRENGTHPEER MEDIANREIT67.9
THE BULL RANKINGS SCORECARD72.6/ 100 · FIN STRENGTHPEER MEDIANREIT72.6
YieldSTAG4.2%TRNO3.4%
RevSTAG+10.1%TRNO+24.5%
D/ESTAG0.94TRNO0.21
STAG
TRNO
4.2%B+
Yield
3.4%B
+10.1%B
Rev
+24.5%A-
0.94B
D/E
0.21A
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
STAGSTAG Industrial, Inc.
REIT - Industrial · $37.07 · beta 0.97
Why now
REIT - Industrial · market cap $7.3b. 13% off the 52-week high of $42.61. Revenue growing +10%, comfortably above the S&P median. 12 sell-side analysts rate this a Buy with a mean 1-yr target of $42.08 (implying +14% upside).
Moat
Net margin 28% sits well above the S&P median (~11%) — suggests structural pricing advantage or cost discipline competitors can't quickly close.
Risk
Dividend payout 117% of earnings on a 4.2% yield — distribution coverage is thin; one earnings stumble could force a dividend cut. ROE 7% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
TRNOTerreno Realty Corporation
REIT - Industrial · $67.11 · beta 1.05
Why now
REIT - Industrial · market cap $7.3b. 15% off the 52-week high of $78.94. Revenue growing +25%, comfortably above the S&P median. 17 sell-side analysts rate this a Buy with a mean 1-yr target of $73.76 (implying +10% upside).
Moat
Net margin 77% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma.
Risk
P/S 14.5x embeds aggressive forward growth — disappointing top-line guidance would compress the multiple hard.
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.